Copyright © 2001 by the European Society of Cardiology.
Editorial
Quest for an optimal population cardiovascular risk factor burden
Framington Heart Study, National Heart, Lung and Blood Institute Boston University School of Medicine, Boston, MA, U.S.A.
References
- Rosengren A, Dotevall A, Eriksson H, Wilhelmsen L. Optimal risk factors in the population: prognosis, prevalence and secular trends. Data from Göteborg population studies. Eur Heart J. 2001;22:136144
[Abstract/Free Full Text] - Lloyd-Jones DM, Larson MG, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353:8992[CrossRef][Web of Science][Medline]
- Morbidity and mortality: 1998 Chartbook on cardiovascular, lung and blood diseases. : National Institutes of Health; 1998.
- Health, United States, 1998. Hyattsville: Socioeconomic and Health Chartbook; 1998.
- Hunink MG, Goldman L, Tosteson ANA. The recent decline in mortality from coronary heart disease 19801990: the effect of secular trends in risk factors and treatment. JAMA. 1997;277:535542
[Abstract/Free Full Text] - Sytkowski PA, DAgostino RB, Belanger A, Kannel WB. Sex and time trends in cardiovascular disease incidence and mor-tality: the Framingham Study, 19501989. Am J Epidemiol. 1996;143:338350
[Abstract/Free Full Text] - Greenland P, Grundy S, Pasternac RC, Lenfant C. Problems on the pathway from risk assessment to risk reduction. Circulation. 1998;97:17611762
[Free Full Text] - American Heart Association, 1998, Heart and Stroke Statistical Update, 1997
- Krumholz HM, Radford MJ, Wang Y. National use and effectiveness of beta blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA. 1998;280:623629
[Abstract/Free Full Text] - Tsevat J, Weinstein MC, Williams LW. Expected gains in life expectancy from various coronary risk factor modifications. Circulation. 1991;83:11941201
[Abstract/Free Full Text] - Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:13601369
- Murray, CJL, Lopez, AD, The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020, Geneva, World Health Organization, 1996
- Rouleau JL, Talasic N, Sussex B. Myocardial infarction in patients in the 1990stheir risk factors, stratification and survival in Canada: The Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol. 1996;27:11191127[Abstract]
- Torp-Pedersen C, Hildebrandt P, Køber L. Improving long-term survival of patients with acute myocardial infarction from 19771988 in a region of Denmark. Eur Heart J. 1995;16:1420[Web of Science][Medline]
- Uemara K, Piza Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q. 1988;:155178
- Smith SC Jr. Lessons from cholesterol lowering trials. Am J Med. 1998;104:28S32S[CrossRef][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||